Plus, why it is perhaps maybe maybe not actually ‘female Viagra.’
On Friday, the Food And Drug Administration authorized a brand new drug meant to boost feminine libido, just the 2nd of its sort to go into the marketplace. Vyleesi, which will be being touted as “female Viagra,” claims to function as solution that women with low libido have already been looking forward to, nonetheless it hasn’t come without debate.
Vyleesi, whose name that is generic bremelanotide, follows the 2015 launch for the medication Addyi, a daily pill designed to treat hypoactive low sexual interest disorder (HSDD) in premenopausal women. While Vyleesi can also be authorized to deal with HSDD, it varies from Addyi as it is available in the type of an injectable in place of a product and is simply to be utilized before intercourse in place of on a day-to-day basis. (Vyleesi is scheduled to be obtainable in and also the drugmaker have not yet determined rates or reimbursement information. september)